Literature DB >> 19176311

Expression of ovarian tumour suppressor OPCML in the female CD-1 mouse reproductive tract.

Jean S Fleming1, H James McQuillan, Melanie J Millier, Grant C Sellar.   

Abstract

Opioid binding protein/cell adhesion molecule-like gene (OPCML) is frequently inactivated in epithelial ovarian cancer, but the role of this membrane protein in normal reproductive function is unclear. The ovarian surface epithelium (OSE) is thought to be the cell of origin of most epithelial ovarian cancers, some of which arise after transformation of OSE cells lining ovarian inclusion cysts, formed during ovulation. We used immunohistochemistry, immunoblotting and quantitative RT-PCR (qRT-PCR) to investigate OPCML expression in the uteri and ovaries of cycling 3-month CD-1 mice, as well as in ovaries from older mice containing inclusion cysts derived from rete ovarii tubules. Immunoblotting showed OPCML bands in uterine, but not whole ovarian or muscle extracts. Strong OPCML immunoreactivity was observed in oviduct, rete ovarii and uterus, whereas in ovary more immunoreactivity was seen in granulosa cells than OSE. No staining was observed in OSE around ovulation sites, where OSE cells divide to cover the site. OPCML immunoreactivity was also weaker in more dysplastic cells lining large ovarian inclusion cysts, compared with normal rete ovarii. No significant changes in Opcml mRNA expression were observed in whole ovarian and uterine extracts at different stages of the cycle. We conclude that murine OPCML is more consistently expressed in cells lining the uterus, oviduct and rete ovarii than in ovary and is not expressed in OSE associated with ovulation sites. This observation supports the hypothesis that a proportion of epithelial ovarian cancers arise from ductal cells and other epithelia of the secondary Mullerian system, rather than the OSE.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19176311      PMCID: PMC2665191          DOI: 10.1530/REP-08-0511

Source DB:  PubMed          Journal:  Reproduction        ISSN: 1470-1626            Impact factor:   3.906


  33 in total

1.  The IgLON family in epithelial ovarian cancer: expression profiles and clinicopathologic correlates.

Authors:  Evangelos Ntougkos; Robert Rush; Diane Scott; Tobias Frankenberg; Hani Gabra; John F Smyth; Grant C Sellar
Journal:  Clin Cancer Res       Date:  2005-08-15       Impact factor: 12.531

2.  The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome.

Authors:  Fabiola Medeiros; Michael G Muto; Yonghee Lee; Julia A Elvin; Michael J Callahan; Colleen Feltmate; Judy E Garber; Daniel W Cramer; Christopher P Crum
Journal:  Am J Surg Pathol       Date:  2006-02       Impact factor: 6.394

3.  CpG island methylation of DNA damage response genes in advanced ovarian cancer.

Authors:  Jens M Teodoridis; Jacqueline Hall; Sharon Marsh; Hilary D Kannall; Catriona Smyth; Jorge Curto; Nadeem Siddiqui; Hani Gabra; Howard L McLeod; Gordon Strathdee; Robert Brown
Journal:  Cancer Res       Date:  2005-10-01       Impact factor: 12.701

Review 4.  Incessant ovulation, inflammation and epithelial ovarian carcinogenesis: revisiting old hypotheses.

Authors:  Jean S Fleming; Clare R Beaugié; Izhak Haviv; Georgia Chenevix-Trench; Olivia L Tan
Journal:  Mol Cell Endocrinol       Date:  2005-11-16       Impact factor: 4.102

5.  Characterization and tissue distribution of opioid-binding cell adhesion molecule (OBCAM) using monoclonal antibodies.

Authors:  A Hachisuka; T Yamazaki; J Sawada; T Terao
Journal:  Neurochem Int       Date:  1996-04       Impact factor: 3.921

6.  Location of inclusion cysts in mouse ovaries in relation to age, pregnancy, and total ovulation number: implications for ovarian cancer?

Authors:  Olivia L Tan; Peter R Hurst; Jean S Fleming
Journal:  J Pathol       Date:  2005-03       Impact factor: 7.996

7.  [*OPCML gene transferred by recombinant lentiviruses in vitro and its inhibition to ovarian cancer cells].

Authors:  De-sheng Yao; Li Li; Kenneth Garson; Barbara C Vanderhyden
Journal:  Zhonghua Fu Chan Ke Za Zhi       Date:  2006-05

8.  RAS-mediated epigenetic inactivation of OPCML in oncogenic transformation of human ovarian surface epithelial cells.

Authors:  Fang C Mei; Travis W Young; Jinsong Liu; Xiaodong Cheng
Journal:  FASEB J       Date:  2005-12-29       Impact factor: 5.191

9.  Active opioid binding protein from rat brain--a glycoprotein containing alpha-methyl-D-mannoside residues.

Authors:  F Wang; Z Y Li; Z Q Chi; Z K Zeng; G Y Zong
Journal:  Zhongguo Yao Li Xue Bao       Date:  1989-11

10.  Polarized targeting of IgLON cell adhesion molecule OBCAM to dendrites in cultured neurons.

Authors:  Seiji Miyata; Naoko Matsumoto; Shohei Maekawa
Journal:  Brain Res       Date:  2003-07-25       Impact factor: 3.252

View more
  1 in total

1.  New roles opined for OPCML.

Authors:  Sherry Y Wu; Anil K Sood
Journal:  Cancer Discov       Date:  2012-02       Impact factor: 39.397

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.